US Suboxone Win Lifts Dr Reddy’s As Embattled Indivior Fights On

 
• By Anju Ghangurde

Dr Reddy’s can re-launch its generic version of Indivior’s Suboxone (buprenorphine/naloxone) sublingual film in the US following a crucial court ruling that has gone its way. Indivior faces significant turbulence ahead if a generic entry materializes soon.

Patent law
A US COURT HAS RULED IN DR REDDY'S FAVOUR IN A CASE AGAINST INDIVIOR

More from Business

More from Scrip